Reports Library Publication
Insight Consumer Healthcare Europe October / November 2025
24th November 2025 by CHC Insight
- Derma Growth slows in most markets
- DB6 MAT Q2 2025 Global retail CHC market continued to decelerate
- Derma Non-cores Karo extends Decubal while Bayer invests in Bepanthen
- Innovation Round-up Market-first launches in Russia, Germany and Sweden
- News Review Spotlight on M&A as Kimberly-Clark set to acquire Kenvue
Order this report
Why buy this report?
"Our dermatologicals report reveals an overall slowdown vs the year-ago period, with consumers likely foregoing non-essential purchases amid the cost-of-living crisis, while the online and social commerce channels (not included in our topline) may be particularly attractive to the younger demographic. Marketers did see some rewards for innovation however, with acne remedies a highlight as multiple spot patches were launched, offering treatment and protection. We have also seen increased integration of AI by some retailers and marketers, with tools offered to analyse skin type and recommend products, as well as track treatment progress."
Nicholas Hall